{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:24Z","timestamp":1786650024951,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vascular endothelial growth factor (VEGF) overexpression is linked to aggressive metastasis and poor prognosis in patients with breast cancer. This study aimed to develop a noninvasive model integrating ultrasound and clinical information for VEGF prediction and to evaluate its clinical utility in risk stratification for lymph metastasis and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Breast cancer ultrasound findings, clinical data, immunohistochemical results, and prognostic information were collected from three centers to develop the intelligent model. ResNet-50 was used to extract ultrasound features, which were then combined with clinical information using logistic regression. Class activation mapping and an alignment nomogram were used to visualize and explain the model\u2019s prediction process. Model performance was assessed using the area under the curve (AUC), confusion matrix, calibration curves, and decision curve analysis. Prognostic relevance was evaluated by examining the lymph node metastasis and recurrence-free survival (RFS) rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Data from 609 patients were divided into four sets: training, validation, internal test, and external test. The combined model demonstrated satisfactory performance in the internal (AUC, 0.852; 95% confidence interval [CI], 0.756\u20130.928) and external (AUC, 0.837; 95% CI, 0.778\u20130.892) test sets. In the external test set, high-risk VEGF patients predicted by the combined model exhibited higher lymph node metastasis rates (67.8% vs. 12.1%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and poorer RFS (log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.022). The prognostic accuracy for recurrence peaked at six months (AUC, 0.806).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This noninvasive intelligent model could precisely predict VEGF expression, indicate the risk of lymph node metastasis, and provide prognostic insights.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1202_25","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:00:35Z","timestamp":1767189635000},"page":"1161-1169","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A multimodal intelligent model for the noninvasive prediction of vascular endothelial growth factor expression and prognostic stratification in breast cancer: A multicenter retrospective study"],"prefix":"10.4103","volume":"21","author":[{"given":"Yue","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Ultrasound, Affiliated Hospital of Jiangnan University, Wuxi, 214000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuxi Medical College of Jiangnan University, Wuxi, 214000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Chinese PLA General Hospital, Beijing, 100010, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Affiliated Hospital of Jiangnan University, Wuxi, 214000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuxi Medical College of Jiangnan University, Wuxi, 214000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260102","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Rebecca","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260102","doi-asserted-by":"crossref","first-page":"ITC161","DOI":"10.7326\/AITC202311210","article-title":"Breast cancer screening and prevention","volume":"176","author":"Amy","year":"2023","journal-title":"Ann Intern Med"},{"key":"R3-20260102","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.23.02311","article-title":"Racial differences in breast cancer survival between black and white women according to tumor subtype:A systematic review and meta-analysis","volume":"42","author":"Torres","year":"2024","journal-title":"J Clin Oncol"},{"key":"R4-20260102","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1200\/JCO-24-01295","article-title":"Navigating treatment pathways in metastatic hormone receptor-positive, HER2-negative breast cancer:Optimizing second-line endocrine and targeted therapies","volume":"42","author":"Prarthna","year":"2024","journal-title":"J Clin Oncol"},{"key":"R5-20260102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer:Pathogenesis and treatments","volume":"10","author":"Xin","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R6-20260102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Natalie","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R7-20260102","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1158\/1078-0432.CCR-23-4020","article-title":"Gene expression assays to tailor adjuvant endocrine therapy for HR+\/HER2- breast cancer","volume":"30","author":"Michele","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R8-20260102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer:Molecular features and clinical significance","volume":"9","author":"Jing","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R9-20260102","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-025-07426-1","article-title":"Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment","volume":"16","author":"Ersilia","year":"2025","journal-title":"Cell Death Dis"},{"key":"R10-20260102","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/pharmaceutics14071369","article-title":"Co-delivery of repurposing itraconazole and VEGF siRNA by composite nanoparticulate system for collaborative anti-angiogenesis and anti-tumor efficacy against breast cancer","volume":"14","author":"Mingji","year":"2022","journal-title":"Pharmaceutics"},{"key":"R11-20260102","first-page":"227","article-title":"How VEGF-A and its splice variants affect breast cancer development \u2013Clinical implications","volume":"45","author":"Hivin","year":"2022","journal-title":"Cell Oncol (Dordr)"},{"key":"R12-20260102","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.3390\/jcm10225452","article-title":"Plasma levels and diagnostic utility of VEGF in a three-year follow-up of patients with breast cancer","volume":"10","author":"Gra\u017cyna","year":"2021","journal-title":"J Clin Med"},{"key":"R13-20260102","doi-asserted-by":"crossref","first-page":"12268","DOI":"10.1038\/s41598-023-37654-4","article-title":"Suppression of VEGF and inflammatory cytokines, modulation of Annexin A1 and organ functions by galloylquinic acids in breast cancer model","volume":"13","author":"Mohamed","year":"2023","journal-title":"Sci Rep"},{"key":"R14-20260102","doi-asserted-by":"crossref","first-page":"eadf1128","DOI":"10.1126\/scitranslmed.adf1128","article-title":"Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer","volume":"15","author":"Zhiwen","year":"2023","journal-title":"Sci Transl Med"},{"key":"R15-20260102","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-23-0757","article-title":"Molecular residual disease in breast cancer:Detection and therapeutic interception","volume":"29","author":"Arielle","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R16-20260102","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2024.02.002","article-title":"Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities","volume":"45","author":"Siyu","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"R17-20260102","first-page":"114041","article-title":"Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells:CAM assay and 3D endothelial cell spheroids","volume":"157","author":"Aurora","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R18-20260102","doi-asserted-by":"crossref","first-page":"e2401436","DOI":"10.1002\/adhm.202401436","article-title":"Bioactive nanotherapeutic ultrasound contrast agent for concurrent breast cancer ultrasound imaging and treatment","volume":"13","author":"Junyue","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"R19-20260102","first-page":"71","article-title":"Global stage distribution of breast cancer at diagnosis:A systematic review and meta-analysis","volume":"10","author":"David","year":"2023","journal-title":"JAMA Oncol"},{"key":"R20-20260102","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/j.clbc.2025.01.005","article-title":"Study on the differentiation of infiltrating breast cancer molecular subtypes based on ultrasound radiomics","volume":"25","author":"Hanqin","year":"2025","journal-title":"Clin Breast Cancer"},{"key":"R21-20260102","doi-asserted-by":"crossref","first-page":"e1004408","DOI":"10.1371\/journal.pmed.1004408","article-title":"Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer:A Phase 1 clinical trial","volume":"21","author":"Daniel","year":"2024","journal-title":"PLoS Med"},{"key":"R22-20260102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/radiol.2019182716","article-title":"A deep learning mammography-based model for improved breast cancer risk prediction","volume":"292","author":"Yala","year":"2019","journal-title":"Radiology"},{"key":"R23-20260102","doi-asserted-by":"crossref","first-page":"100054","DOI":"10.1016\/j.dte.2025.100054","article-title":"Artificial intelligence system assists doctors to improve the treatment effect of microwave ablation on hepatocellular carcinoma:A prospective cohort study","volume":"6","author":"Ding","year":"2025","journal-title":"Digital Engineering"},{"key":"R24-20260102","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jhep.2025.01.011","article-title":"Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions","volume":"83","author":"Ding","year":"2025","journal-title":"J Hepatol"},{"key":"R25-20260102","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41467-020-15027-z","article-title":"Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"R26-20260102","doi-asserted-by":"crossref","first-page":"e222646","DOI":"10.1148\/radiol.222646","article-title":"Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers","volume":"308","author":"Ramtohul","year":"2023","journal-title":"Radiology"},{"key":"R27-20260102","doi-asserted-by":"crossref","first-page":"104706","DOI":"10.1016\/j.ebiom.2023.104706","article-title":"Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers","volume":"94","author":"Huang","year":"2023","journal-title":"eBioMedicine"}],"updated-by":[{"DOI":"10.4103\/jcrt.jcrt_798_26","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000}}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1202_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:10Z","timestamp":1786647670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1202_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1202_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-06-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}